TL;DR
This retrospective study demonstrates that implementing an Enhanced Recovery After Surgery (ERAS) protocol for children undergoing major hip osteotomies significantly reduces hospital stays (from 10 to 6 days) and improves pain management. The findings suggest that ERAS is not only safe for pediatric populations but also highly effective in accelerating physiological recovery without increasing complication rates.
What Problem Does This Paper Address?
Developmental dysplasia of the hip (DDH) is a common pediatric bone deformity. When diagnosed in children older than 18 months, the standard treatment is often a complex surgery known as an osteotomy (cutting and reshaping bone). Traditionally, these surgeries involve long hospital stays, significant postoperative pain, and slow returns to normal function.
While Enhanced Recovery After Surgery (ERAS)—a multidisciplinary, evidence-based approach to perioperative care—has revolutionized adult orthopedics (like hip and knee replacements), its application in major pediatric surgery has been limited. Children are a "special attention" group, and there has been a lack of robust data on whether adult ERAS protocols can be safely and effectively adapted for them. This paper seeks to fill that gap by comparing a newly implemented ERAS protocol against traditional care for pediatric DDH patients.
Methods
The researchers conducted a retrospective case-cohort study at Wuhan Union Hospital, comparing two groups of children who underwent unilateral hip osteotomies:
- Control Group (n=82): Received traditional care between January 2014 and December 2015.
- ERAS Group (n=86): Followed a new ERAS protocol between January 2016 and December 2017.
The ERAS protocol included several key shifts from standard practice: * Preoperative: Shortened fasting (clear fluids up to 2 hours before anesthesia vs. the traditional 4+ hours) and intensive parental education. * Intraoperative: Strict temperature control (24°C) and warm fluids to prevent hypothermia. * Postoperative: Multimodal analgesia (local infiltration of ropivacaine + non-steroidal anti-inflammatories) to reduce opioid use, early oral food intake, and early removal of urinary catheters (within 24 hours) and drainage tubes (within 48 hours).
Datasets
The study utilized retrospective hospital medical records from Wuhan Union Hospital. The cohort included children with DDH undergoing unilateral pelvic and proximal femoral osteotomies. Patients with prior neuromuscular diseases, cerebral palsy, or scoliosis were excluded to maintain a homogenous study population.
Key Insights and Ideas
- The "Kid-Specific" ERAS Challenge: Unlike adults, children cannot be easily "mobilized" (walking) immediately after hip surgery because they are often placed in a Spica cast for six weeks. The study shows that ERAS can still be effective by focusing on other physiological markers like early eating and tube removal.
- Multimodal Analgesia is Key but Difficult: While the ERAS group had significantly lower pain scores, compliance with "analgesia infusion pumps" was lower than other components (75.6%). This was attributed to parental and clinician concerns regarding the adverse effects of opiates (sufentanil/oxycodone) in children.
- Temperature Management Matters: The ERAS group saw a lower frequency of postoperative fever. The authors hypothesize this is due to better intraoperative temperature monitoring, suggesting that "surgical fever" may often be a thermoregulation issue rather than just an inflammatory response.
- Safety of Early "De-tubing": Removing catheters and drains significantly earlier did not lead to increased urinary infections or hematomas, challenging the traditional "play it safe" approach of leaving tubes in for several days.
Key Results
The ERAS protocol led to statistically significant improvements across nearly all recovery metrics ($P < 0.001$ for most):
- Hospital Stay: Reduced from 10.0 ± 3.1 days to 6.0 ± 0.8 days.
- Pain Management: Mean 3-day Visual Analogue Scale (VAS) scores dropped from 4.0 to 2.9.
- First Eating Time: Reduced from 12.2 hours to 5.2 hours post-surgery.
- Catheter Removal: Occurred at 10.0 hours in the ERAS group vs. 54.2 hours in the control group.
- Complications: There were no serious complications in either group, and the incidence of postoperative fever was significantly lower in the ERAS group ($P = 0.002$).
Limitations and Future Work
- Retrospective Nature: As a retrospective study, it is subject to inherent biases; a prospective randomized controlled trial (RCT) would provide higher-level evidence.
- Single-Center Study: The results reflect the practices of one high-volume institution. Multi-center studies are needed to see if these results are reproducible across different hospital settings.
- Economic Analysis: While the stay was shorter, the study did not perform a formal cost-benefit analysis to see if the increased cost of multimodal analgesia and specialized nursing was offset by the reduced hospitalization time.
- Long-term Follow-up: The study focused on the immediate perioperative period; long-term functional outcomes of the hip joint following ERAS were not discussed.
Summary updated